Richard Saintvilus

Richard Saintvilus

InvestorPlace Contributor

After 20 successful years in the IT industry, Richard Saintvilus decided his second act would be as a stock analyst. Saintvilus founded WallStPlaybook.com to help educate investors about the highs and lows of the stock market and ways to grow and preserve their wealth. His work has been featured on CNBC, Yahoo! Finance, USA Today, MSN Money, Forbes, and numerous other outlets. You can follow him on Twitter at @Richard_Stv.

Recent Articles

Can Wells Fargo & Co. (WFC) Win Back Its Credibility?

By Richard Saintvilus, InvestorPlace Contributor

With lowered headline risks and an improved regulatory environment, Wells Fargo (WFC) can revive its business and send WFC stock higher.

Biogen Inc (BIIB) Stock Should Move Higher in 2017

By Richard Saintvilus, InvestorPlace Contributor

There are plenty of tailwinds coming up for Biogen, and the valuation on BIIB stock right now presents an opportunity for investors.

Why Tesla Motors Inc (TSLA) Will Gain 20% in 2017

By Richard Saintvilus, InvestorPlace Contributor

While Tesla Motors (TSLA) is spending tons of cash to deliver on aggressive production totals, it's tough to bet against TSLA stock.

McDonald’s Corporation Shakes Up C-Suite to Revive Sales (MCD)

By Richard Saintvilus, InvestorPlace Contributor

Despite executive departures, McDonald’s stock is in solid hands with CEO Easterbrook. MCD is now on the value menu.

Valeant Pharmaceuticals Intl Inc (VRX) Has a Chance to Outperform After Earnings

By Richard Saintvilus, InvestorPlace Contributor

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will report third-quarter fiscal 2016 earning results on Tuesday before the opening bell.

Load More